Literature DB >> 11135250

Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis.

J R Tonra1, B S Reiseter, R Kolbeck, K Nagashima, R Robertson, B Keyt, R M Lindsay.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an animal model for human multiple sclerosis (MS). Similar to MS patients, EAE animals can exhibit chronic or relapsing, remitting paralysis; leukocyte infiltration of the central nervous system (CNS); and breakdown of the blood-brain barrier (BBB), allowing access to serum components. EAE pathology in rodents is generally thought to progress from the spinal cord to the more rostral brain. This common notion is based on numerous reports on the severity and progression of cellular infiltration and BBB breakdown during the course of disease. We studied opening of the BBB in EAE mice immunized to the proteolipid protein (PLP) peptide, PLP 139-151, with or without the use of pertussis toxin. Peripherally injected rabbit immunoglobulin G showed significant penetration through a compromised BBB in EAE mice and was observed throughout the parenchyma as well as intracellularly in multiple neuronal types. Results demonstrate the novel finding that the cerebellar BBB is dramatically and briefly comprised, even before breakdown of the BBB in the thoracolumbar spinal cord and prior to symptomatic disease. The demonstration of susceptibility in the cerebellum provides an important target for studying the factors predisposing certain CNS regions to autoimmune-related compromise of the BBB, such as MS. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135250

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  25 in total

1.  Suppression of EAE and prevention of blood-brain barrier breakdown after vaccination with novel bifunctional peptide inhibitor.

Authors:  Ahmed H Badawi; Paul Kiptoo; Wen-Tung Wang; In-Young Choi; Phil Lee; Charlotte M Vines; Teruna J Siahaan
Journal:  Neuropharmacology       Date:  2011-12-17       Impact factor: 5.250

Review 2.  Nanoparticle transport across the blood brain barrier.

Authors:  Andreas M Grabrucker; Barbara Ruozi; Daniela Belletti; Francesca Pederzoli; Flavio Forni; Maria Angela Vandelli; Giovanni Tosi
Journal:  Tissue Barriers       Date:  2016-02-25

3.  Selective protection of murine cerebral Gi/o-proteins from inactivation by parenterally injected pertussis toxin.

Authors:  Salvador Castaneda Vega; Veronika Leiss; Roland Piekorz; Carsten Calaminus; Katja Pexa; Marta Vuozzo; Andreas M Schmid; Vasudharani Devanathan; Christian Kesenheimer; Bernd J Pichler; Sandra Beer-Hammer; Bernd Nürnberg
Journal:  J Mol Med (Berl)       Date:  2019-12-06       Impact factor: 4.599

Review 4.  Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.

Authors:  Abbas Mirshafiey; Ghasem Ghalamfarsa; Babak Asghari; Gholamreza Azizi
Journal:  Innov Clin Neurosci       Date:  2014-07

5.  Controlling immune response and demyelination using highly potent bifunctional peptide inhibitors in the suppression of experimental autoimmune encephalomyelitis.

Authors:  P Kiptoo; B Büyüktimkin; A H Badawi; J Stewart; R Ridwan; T J Siahaan
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

Review 6.  The role of microglia in central nervous system immunity and glioma immunology.

Authors:  Isaac Yang; Seunggu J Han; Gurvinder Kaur; Courtney Crane; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2009-11-18       Impact factor: 1.961

7.  Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation.

Authors:  Sarah E Lutz; Julian R Smith; Dae Hwan Kim; Carl V L Olson; Kyle Ellefsen; Jennifer M Bates; Sunil P Gandhi; Dritan Agalliu
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

8.  von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis.

Authors:  Rajkumar Noubade; Roxana del Rio; Benjamin McElvany; James F Zachary; Jason M Millward; Denisa D Wagner; Halina Offner; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

9.  Cerebellar susceptibility to experimental autoimmune encephalomyelitis in SJL/J mice: potential interaction of immunology with vascular anatomy.

Authors:  James R Tonra
Journal:  Cerebellum       Date:  2002 Jan-Mar       Impact factor: 3.847

10.  Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein.

Authors:  Sergei Spitsin; Carla Portocarrero; Timothy W Phares; Rhonda B Kean; Christine M Brimer; Hilary Koprowski; D Craig Hooper
Journal:  J Neuroimmunol       Date:  2008-04-11       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.